Mai Capital Management Cel Sci Corp Transaction History
Mai Capital Management
- $13 Billion
- Q1 2025
A detailed history of Mai Capital Management transactions in Cel Sci Corp stock. As of the latest transaction made, Mai Capital Management holds 526,480 shares of CVM stock, worth $4.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
526,480
Previous 159,600
229.87%
Holding current value
$4.02 Million
Previous $63,000
92.06%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CVM
# of Institutions
38Shares Held
2.69MCall Options Held
73.8KPut Options Held
106K-
Black Rock Inc. New York, NY775KShares$5.91 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ298KShares$2.27 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY217KShares$1.66 Million0.0% of portfolio
-
State Street Corp Boston, MA215KShares$1.64 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL118KShares$902,7200.0% of portfolio
About CEL SCI CORP
- Ticker CVM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,367,500
- Market Cap $331M
- Description
- CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...